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Barley limit dextrinase (HvLD) is a debranching enzyme from glycoside
hydrolase family 13 subfamily 13 (GH13_13) that hydrolyses -1,6-glucosidic
linkages in limit dextrins derived from amylopectin. The structure of HvLD was
solved and refined to 1.9 A˚ resolution. The structure has a glycerol molecule
in the active site and is virtually identical to the structures of HvLD in complex
with the competitive inhibitors -cyclodextrin and -cyclodextrin solved to
2.5 and 2.1 A˚ resolution, respectively. However, three loops in the N-terminal
domain that are shown here to resemble carbohydrate-binding module family 21
were traceable and were included in the present HvLD structure but were too
flexible to be traced and included in the structures of the two HvLD–inhibitor
complexes.
1. Introduction
Barley limit dextrinase (HvLD) catalyses the debranching of limit
dextrins derived from amylopectin, the major constituent of barley
starch. Starch amounts to 60% of the total dry weight of cereal grains
and consists of an approximately 30:70 mixture of the essentially
linear -1,4-glucan amylose and the -1,6-branched -1,4-glucan
amylopectin. Enzyme-mediated mobilization of storage starch
granules in the endosperm of germinating cereal seeds involves
solubilization by the concerted action of -amylase, -amylase, limit
dextrinase (LD) and -glucosidase, resulting in dextrins, maltooligo-
saccharides and glucose. Among these enzymes, only LD has the
capacity to hydrolyse -1,6-glucosidic linkages in branched -limit
and -limit dextrins (Kristensen et al., 1999). In addition, LD can
hydrolyse -1,6-glucosidic linkages in pullulan and, with low effi-
ciency, 1,6-branch points in amylopectin (Kristensen et al., 1999;
Burton et al., 1999). LD catalyses hydrolysis via the general acid/base
double-displacement mechanism characteristic of glycoside hydrolase
family 13 (GH13; Cantarel et al., 2009; MacGregor et al., 2001) by the
action of a catalytic nucleophile Asp473 (numbering refers to HvLD;
Q9S7S8) and a catalytic acid/base proton donor Glu510, resulting
in retention of the anomeric configuration of the products. Recently,
expression of HvLD has successfully been established in Pichia
pastoris (Vester-Christensen, Abou Hachem, Naested et al., 2010).
The crystal structures of HvLD in complex with the competitive
inhibitors -cyclodextrin (-CD) and -cyclodextrin (-CD) have
been solved and refined to 2.5 and 2.1 A˚ resolution, respectively
(Vester-Christensen, Abou Hachem, Svensson et al., 2010).HvLD has
four structural domains: the N-domain (residues 1–124), a carbo-
hydrate-binding module from family 48 (CBM48; residues 125–230),
the catalytic domain (residues 231–774) and the C-domain (residues
775–885). The structures of HvLD–-CD and HvLD–-CD showed
overall good electron density, but the two first amino-acid residues
and three loops (residues 23–27, 42–48 and 102–109) in the N-domain
have low-level or no A-weighted 2Fo  Fc electron density and were
not included in the model (Vester-Christensen, Abou Hachem,
Svensson et al., 2010). The function of the N-domain is not clear, but it
# 2012 International Union of Crystallography
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is typical of GH13 enzymes that cleave or form endo--1,6-linkages
(Jespersen et al., 1991) and hence is presumed to have a functional
linkage to this specificity. In this paper, we report the 1.9 A˚ resolution
X-ray crystallographic structure of HvLD, including a fully traced
backbone of the N-domain which, in spite of a low sequence identity
of 6%, can also be seen to possess structural similarity to the N-
terminal CBM21 domain of glucoamylase from Rhizopus oryzae (Liu
et al., 2007).
2. Materials and methods
2.1. Crystallization, data collection and processing, structure
determination and refinement
Recombinant HvLD was prepared using P. pastoris as a host and
was purified as described previously (Vester-Christensen, Abou
Hachem, Naested et al., 2010). The protein was concentrated to
10 mg ml1 in 50 mM MES buffer pH 6.6, 250 mM NaCl, 0.5 mM
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Figure 1
(a) Overall structure of HvLD in two orientations. N-domain, orange; CBM48, blue; catalytic domain, grey; C-domain, green; Ca2+, red; I, purple; GOL, green sticks. The
catalytic residues (Asp473, Glu510 and Asp642) are shown as black sticks. (b) Comparison of the N-terminal domain of HvLD (orange) with the same domain of HvLD in
complex with -CD (cyan) or -CD (purple). The missing loops are indicated by arrows. (c) Superposition of the amino-acid residues of the active sites of HvLD (orange)
and the HvLD–-CD structure (grey). GOL1888 is shown in green.
CaCl2, 0.67 mM maltotriose, resulting in a sixfold molar excess of
maltotriose, and crystals of HvLD were obtained by hanging-drop
vapour diffusion at 293 K. Optimized crystals were obtained by
streak-seeding using a reservoir solution consisting of 30%(w/v)
polyethylene glycol (PEG) 3350, 5% glycerol, 0.3M NaI. Cysteine
was added to the crystallization drops to a final concentration of 5–
7 mM. Crystals appeared within one week. The HvLD crystals were
cryoprotected by changing the PEG 3350 concentration of the drops
to approximately 35% by stepwise addition of 35%(w/v) PEG 3350,
5% glycerol, 0.3MNaI to the drop until cryoprotection was achieved.
The crystals were mounted on Mesh LithoLoops (0.2 mm loop size
and 40 mm mesh size; Molecular Dimensions, Newmarket, England)
and flash-cooled in liquid nitrogen.
X-ray diffraction data were collected on beamline ID23-1 at the
European Synchroton Radiation Facility (ESRF; Grenoble, France)
with  = 0.976 A˚. The data were integrated using MOSFLM (Leslie,
1992) and scaled with SCALA from the CCP4 program suite (Winn
et al., 2011). The resulting structure factors were used for molecular
replacement (MR) using MOLREP (Vagin & Teplyakov, 1997) from
the CCP4 suite and theHvLD–-CD model (PDB entry 2y4s; Vester-
Christensen, Abou Hachem, Svensson et al., 2010) including only the
protein moiety. The model was refined using REFMAC5 (Murshudov
et al., 2011). Manual inspection, rebuilding and addition of water
molecules and ions were performed with Coot (Emsley et al., 2010).
In addition to the Coot validation functions, final analysis of model
geometry optimization was performed using the output from
PROCHECK and MolProbity (Laskowski et al., 1993; Chen et al.,
2010).
Two structure-based alignment tools were used in order to advance
insight into the possible role of the HvLD N-domain (residues
2–124): a DALI search (Holm & Rosenstro¨m, 2010) against all PDB
entries and FATCAT structural alignment (Ye & Godzik, 2003). In
addition, a search using PDBeFold (Krissinel & Henrick, 2004) was
performed, but no additional information was gained. The structure-
based searches were also performed using the N-domain from the
HvLD–-CD structure (PDB entry 2y4s), but the number of signifi-
cant hits was low compared with the searches with the N-domain
from native HvLD owing to the missing loop regions and did not
include the CMB21 domain.
3. Results and discussion
3.1. Structure determination and model quality
Two calcium ions, four iodide ions, four glycerol molecules and 294
water molecules were modelled in HvLD. Refinement statistics are
listed in Table 1. The geometry of the models is good, with 99.7% of
the residues in the allowed regions of the Ramachandran plot and
three residues (Lys107, Leu116 and Ala439) in the disallowed region.
Ala439 is found in a similar position and intramolecular arrangement
as in theHvLD–-CD structure (PDB entry 2y4s) used for molecular
replacement. Lys107 resides in a flexible loop and Leu116 resides in
the third -helix of the N-terminal domain.
3.2. Overall structure
The HvLD structure (Fig. 1a) and the protein moiety of HvLD–
-CD are virtually identical, with an r.m.s.d. of 0.2 A˚ for all C atoms.
The major difference between the structures is that the three short
loops (residues 23–27, 42–48 and 102–109) in the N-domain are
included in the N-domain of the HvLD structure (Fig. 1b), which
consists of seven -strands arranged in an antiparallel fashion and
three -helices.
Four glycerol molecules (Gol) from the crystallization buffer and
the cryoprotectant were found in HvLD (Fig. 1a). Gol1885 is located
at the interface between CBM48 and the catalytic domain and
Gol1886 is located on the exposed surface of the C-domain. Gol1887
is buried in part of loop 2, similar to Gol306 inHvLD–-CD. Gol1888
is found in the active site, interacting with the catalytic nucleophile
Asp473, and shows the same interaction pattern as a glycerol mole-
cule in HvLD–-CD (Fig. 1c).
3.3. Active site
The amino-acid residues in the active site of HvLD are found in a
similar arrangement and adopt the same rotamers as the amino-acid
residues in the HvLD structures with -CD and -CD bound in the
active site (Fig. 1c).
Mikami et al. (2006) observed a substrate-induced conformational
change of the active-site residues connecting the acid/base catalytic
residue (Glu706) and the C2 binding site (Trp708) in the case of the
GH13 pullulanase from Klebsiella pneumoniae, which belongs to the
same subfamily as HvLD according to CAZy (Cantarel et al., 2009).
They observed two different main-chain conformations of the loop
(residues 706–710; EGWDS) depending on whether or not a ligand
(in this case glucose, isomaltose, maltose, maltotriose or malto-
tetraose) was bound. In addition, the side chain of Trp708 made about
a 90 rotation to enable a stacking interaction at the active-site +2
subsite. In the native pullulanase structure (PDB entry 2fgz) and in
the structures with bound glucose (PDB entry 2fh6) or isomaltose
(PDB entry 2fh8) the loop was in the ‘inactive’ free conformation,
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Table 1
Data-collection and refinement statistics.
Values in parentheses are for the outer resolution shell.
Data-collection details
Wavelength (A˚) 0.976
Resolution range (A˚) 33.7–1.90 (2.00–1.90)
Unit-cell parameters (A˚, ) a = 176.1, b = 82.1, c = 59.4,
 = 96.2
Space group C2
No. of observed reflections 156615 (23012)
No. of unique reflections 60352 (9080)
Wilson B factor (A˚2) 17.3
Completeness (%) 91.3 (94.5)
hI/(I)i 7.8 (2.1)
Multiplicity 2.6 (2.5)
Rmerge† 0.113 (0.616)
Rp.i.m.‡ 0.065 (0.349)
Refinement
Reflections used 57222
Rcryst/Rfree (%) 18.9/22.5
No. of protein atoms 7042
No. of calcium ions 2
No. of iodide ions 4
No. of glycerol molecules 4
No. of water molecules 297
Mean B factor (A˚2)
All atoms 21.1
Protein atoms 20.7
Cruickshank’s DPI for coordinate error (A˚)§ 0.2
R.m.s.d. values from ideal
Bond lengths (A˚) 0.008
Bond angles () 1.165
Ramachandran plot
Allowed regions (%) 99.66
Disallowed regions (%) 0.34
MolProbity score 1.26
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the intensity
of the ith observation of reflection hkl and hI(hkl)i is the average over all observations
of reflection hkl. ‡ Rp.i.m. is the multiplicity-weighted Rmerge (Weiss, 2001). § Cruick-
shank’s diffraction-component precision index (DPI) (Cruickshank, 1999).
while the loop was in the ‘active’ conformation in the complexes with
maltose, maltotriose or maltotetraose (PDB entries 2fhb, 2fhc or 2fhf,
respectively; Mikami et al., 2006). The loop is one of the conserved
regions of GH13 (MacGregor et al., 2001) and is also conserved in
HvLD (residues 510–514; EGWDF). In HvLD the loop is found in
the ‘active’ form both in the case of the native structure presented
here and in the HvLD–CD complexes, in which the loop and Trp512
in particular participate in binding. Noticeably, Trp512 of native
HvLD is also in the ‘active’ rotamer position. It may be argued that
the HvLD structure is not in its native state and that the glycerol
molecule (Gol1888; Fig. 1c) in the active site could induce the change
to the ‘active’ form. However, this does not seem to be a valid
explanation since the glycerol molecule is interacting with the cata-
lytic nucleophile Asp473, which is not part of the abovementioned
conserved loop that changes conformation and makes no interactions
with it. A conformational change upon substrate binding has been
observed for several GH13-like enzymes (Barends et al., 2007; Przylas
et al., 2000; Hondoh et al., 2003; Woo et al., 2008), among which is
a GH13 glycogen-debranching enzyme from Sulfolobus solfataricus
(Woo et al., 2008), in which the Trp adopts the same rotamer and is in
the same position as HvLD when substrate is bound.
These findings suggest that HvLD activity is not dependent on
conformational changes of active-site amino-acid residues, unlike the
pullulanase discussed above. This may indicate that the active site of
HvLD is less flexible, possibly explaining the lower hydrolytic activity
of HvLD towards large substrates such as amylopectin and the high
activity towards the oligosaccharide limit dextrins compared with
bacterial pullulanases.
3.4. The N-terminal domain
Superposition of the N-terminal domain of HvLD with those of
the deposited HvLD–-CD and HvLD–-CD complex structures
(Fig. 1b) shows no significant variability in the conformation except
for a different tucking in of the N-terminal amino-acid residues 2–5 to
the rest of the molecule in the HvLD–-CD structure (PDB entry
2y5e; Vester-Christensen, Abou Hachem, Svensson et al., 2010) and
the previously mentioned well defined loop density of the three
flexible loops in the native HvLD structure.
Several alignment methods were explored to advance insight into
the possible role of the HvLD N-domain. A DALI search (Holm &
Rosenstro¨m, 2010) with this domain against the entire PDB archive
identified nine unique structures with DALI Z-scores of above 5
(Supplementary Table 11). Only five of these proteins are -1,6-acting
pullulanases belonging to GH13_13 and GH13_14 and the sequence
identity to HvLD is in general low (see Supplementary Fig. 11).
Common to the hits is that they, like the HvLD N-domain, do not
harbour the active-site residues. Three of the identified domains have
documented, albeit diverse, functions. These include binding of a
peptide ligand, domain multimerization and N-acetyl-d-glucosamine
(NAG) binding (Supplementary Table 11). Noticeably, the parts of
the domains involved in these interactions are not structurally similar
(Fig. 2). The discrepancy between the amino-acid residues involved
in intermolecular interactions and the lack of structural conservation
of the same residues indicate that the various functionalities have
evolved independently, suggesting that the N-terminal domain is a
stable generic scaffold for mediating intermolecular interactions.
FATCAT structural alignment (Ye & Godzik, 2003) with the
complete N-terminal domain as present in HvLD identified only
pullulanase N-terminal domains with a FATCAT P-value of below
1.0  103. Noticeably, the N-terminal starch-binding domain of the
CBM21 glucoamylase from R. oryzae (PDB entry 2djm; Liu et al.,
2007) and the N-domain ofHvLD align with a P-value of 1.44 103
despite having a sequence identity of only 6% (Supplementary
Fig. 21). Ser76, Tyr78, Ser86 and Lys94 of HvLD are the only surface-
exposed residues among the identical residues from the structure-
based sequence alignment, and although they are clustered from a
steric point of view they are located in a part of the domain which
is not structurally conserved (Supplementary Fig. 21). The starch-
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Figure 2
Superposition of the N-domain fromHvLD (orange) and structurally similar domains with documented functions identified by theDALI search. (a) Erythropoietin receptor
(PDB entry 1eba; Livnah et al., 1998; red) and the ligands from the structure: EMP33, an erythropoietin-mimic peptide, and DBY-T, 3,5-dibromotyrosine. (b) Cytokine
receptor -chain (PDB entry 2b5i; Wang et al., 2005; blue) and N-acetyl-d-glucosamine (NAG). (c) Esterase (PDB entry 3doi; Levisson et al., 2009; green) and diethyl
phosphonate (DEP).
1 Supplementary material has been deposited in the IUCr electronic archive
(Reference: HV5219).
binding residues identified in R. oryzae CBM21 (Tung et al., 2008) are
not conserved or are replaced by residues with similar biophysical
properties in HvLD (Supplementary Fig. 2). It therefore seems
unlikely that these residues play similar roles in the two molecules
unless major structural changes occur in HvLD in the presence of
starch. In conclusion, the N-terminal domain of HvLD may partici-
pate in intermolecular interactions that are important for the in vivo
functionality of HvLD, but there are no indications of whether the
interactions involve multimerization, interactions with other proteins
or interactions with substrate.
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